Therapeutic potential of adult stem cells-derived mitochondria transfer combined with curcumin administration into ARPE-19 cells in age-related macular degeneration model

MakaleYalnız künyeScopus SJRQ2
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

Objective: Mitochondria transfer from human Wharton's Jelly-derived mesenchymal stem cells (hWJ-MSCs-mt) and human endometrium-derived mesenchymal stem cells (hE-MSCs-mt), along with curcumin, were explored as potential treatments for age-related macular degeneration (AMD) caused by mitochondrial inefficiency, using a retinal model to assess impacts of curcumin and hWJ-MSCs-mt or hE-MSCs-mt on AMD. Methods: ARPE-19 cells established an in vitro AMD model. Cells were exposed to 0–50 μM curcumin for 24 hours to determine optimal concentration by assessing their viability. Immunofluorescence examined SOD1, TNF-α, and TGF-β levels at optimal hydrogen peroxide (H2O2) concentration. β-galactosidase staining and DCFH analysis evaluated H2O2-induced cellular senescence. Immunofluorescence assessed REP65, CRALBP1 (RLBP1), Pink1, and Parkin expression, whereas qRT-PCR analyzed Nrf2, Ire1a, ARMS2, HTRA1, RPE65, RLBP1, NOX4, and TOMM20 expression following co-treatment with curcumin and hWJ-MSCs-mt or hE-MSCs-mt. Results: Curcumin improved ARPE-19 cell survival under H2O2-induced oxidative stress by regulating SOD1, TNF-α, TGF-β, DCFH, and MDA levels. hWJ-MSCs-mt transfer increased RLBP1 and Parkin expression, whereas curcumin reduced Parkin expression. hE-MSCs-mt transfer upregulated Parkin, RPE65, Pink1, and RLBP1 expressions, with curcumin enhancing RPE65 expression. hWJ-MSCs-mt and curcumin combined more effectively downregulated expressions of stress-related genes (Nrf2, Ire1α, NOX4) and improved expression of mitochondrial function gene (TOMM20). hE-MSCs-mt transfer with curcumin synergistically enhanced expression of retinal health markers (RPE65, RLBP1) and downregulated expression of damage-associated genes (HTRA1, ARMS2) in AMD models. Conclusion: Curcumin combined with hWJ-MSCs-mt or hE-MSCs-mt is a potential AMD therapy owing to its anti-inflammatory properties; however, further in vivo and human studies are needed to confirm its efficacy and safety.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/kostu/10568Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1016/j.tice.2024.102687Yayıncı resmi DOI adresi
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
12
WoS
12
OpenAlex
15
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorKılıç, Kamil Can
dc.contributor.authorDuruksu, Gökhan
dc.contributor.authorÖztürk, Ahmet
dc.contributor.authorRençber, Selenay Furat
dc.contributor.authorKılıç, Buket
dc.contributor.authorYazır, Yusufhan
dc.date.accessioned2026-10-27T23:47:38.621480412Z
dc.date.available2026-10-27T23:47:38.621480412Z
dc.date.issued2025
dc.description.abstractObjective: Mitochondria transfer from human Wharton's Jelly-derived mesenchymal stem cells (hWJ-MSCs-mt) and human endometrium-derived mesenchymal stem cells (hE-MSCs-mt), along with curcumin, were explored as potential treatments for age-related macular degeneration (AMD) caused by mitochondrial inefficiency, using a retinal model to assess impacts of curcumin and hWJ-MSCs-mt or hE-MSCs-mt on AMD. Methods: ARPE-19 cells established an in vitro AMD model. Cells were exposed to 0–50 μM curcumin for 24 hours to determine optimal concentration by assessing their viability. Immunofluorescence examined SOD1, TNF-α, and TGF-β levels at optimal hydrogen peroxide (H2O2) concentration. β-galactosidase staining and DCFH analysis evaluated H2O2-induced cellular senescence. Immunofluorescence assessed REP65, CRALBP1 (RLBP1), Pink1, and Parkin expression, whereas qRT-PCR analyzed Nrf2, Ire1a, ARMS2, HTRA1, RPE65, RLBP1, NOX4, and TOMM20 expression following co-treatment with curcumin and hWJ-MSCs-mt or hE-MSCs-mt. Results: Curcumin improved ARPE-19 cell survival under H2O2-induced oxidative stress by regulating SOD1, TNF-α, TGF-β, DCFH, and MDA levels. hWJ-MSCs-mt transfer increased RLBP1 and Parkin expression, whereas curcumin reduced Parkin expression. hE-MSCs-mt transfer upregulated Parkin, RPE65, Pink1, and RLBP1 expressions, with curcumin enhancing RPE65 expression. hWJ-MSCs-mt and curcumin combined more effectively downregulated expressions of stress-related genes (Nrf2, Ire1α, NOX4) and improved expression of mitochondrial function gene (TOMM20). hE-MSCs-mt transfer with curcumin synergistically enhanced expression of retinal health markers (RPE65, RLBP1) and downregulated expression of damage-associated genes (HTRA1, ARMS2) in AMD models. Conclusion: Curcumin combined with hWJ-MSCs-mt or hE-MSCs-mt is a potential AMD therapy owing to its anti-inflammatory properties; however, further in vivo and human studies are needed to confirm its efficacy and safety.
dc.description.sponsorshipKocaeli Üniversitesi, (TDK-2022-2826)
dc.description.sponsorshipKocaeli Üniversitesi
dc.identifier.articlenumber102687
dc.identifier.doi10.1016/j.tice.2024.102687
dc.identifier.issn0040-8166
dc.identifier.pmid39705870
dc.identifier.scopus2-s2.0-85212423286
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/kostu/10568
dc.identifier.volume93
dc.identifier.wosWOS:001393199600001
dc.language.isoen
dc.publisherElsevier Ltd
dc.relation.ispartofTissue and Cell
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectARPE-19 cells
dc.subjectCurcumin
dc.subjectMacular degeneration
dc.subjectMesenchymal stem cell
dc.subjectMitochondria
dc.subject.classificationAnatomy & Morphology
dc.subject.classificationCell Biology
dc.subject.otherCell Line
dc.subject.otherCurcumin
dc.subject.otherHumans
dc.subject.otherHydrogen Peroxide
dc.subject.otherMacular Degeneration
dc.subject.otherMesenchymal Stem Cells
dc.subject.otherMitochondria
dc.subject.otherModels, Biological
dc.subject.otherRetinal Pigment Epithelium
dc.subject.otherage related maculopathy susceptibility 2 protein
dc.subject.otherautophagy related protein
dc.subject.otherbeta galactosidase
dc.subject.othercopper zinc superoxide dismutase
dc.subject.otherdichlorodihydrofluorescein diacetate
dc.subject.otherparkin
dc.subject.otherprotein IRE1
dc.subject.otherprotein IRE1a
dc.subject.otherprotein pink1
dc.subject.otherreduced nicotinamide adenine dinucleotide phosphate oxidase 4
dc.subject.otherretinal pigment epithelium specific 65
dc.subject.otherretinaldehyde binding protein 1
dc.subject.otherretinoid binding protein
dc.subject.otherserine protease HTRA1
dc.subject.othertranscription factor Nrf2
dc.subject.othertransforming growth factor beta
dc.subject.othertranslocase of outer mitochondrial membrane 20
dc.subject.othertumor necrosis factor
dc.subject.otherunclassified drug
dc.subject.otheradult stem cell
dc.subject.otherantiinflammatory activity
dc.subject.otherARPE-19 cell line
dc.subject.otherArticle
dc.subject.othercell aging
dc.subject.othercell survival
dc.subject.othercell transfer
dc.subject.othercell viability
dc.subject.othercontrolled study
dc.subject.otherdown regulation
dc.subject.otherflow cytometry
dc.subject.othergene expression
dc.subject.otherhuman
dc.subject.otherhuman cell
dc.subject.otherhuman endometrium derived mesenchymal stem cell
dc.subject.otherimmunofluorescence
dc.subject.otherimmunohistochemistry
dc.subject.otherin vitro study
dc.subject.othermesenchymal stem cell
dc.subject.othermitochondrial transfer
dc.subject.otheroxidative stress
dc.subject.otherpreclinical study
dc.subject.otherprotein expression
dc.subject.otherreal time polymerase chain reaction
dc.subject.otherupregulation
dc.subject.otherwet macular degeneration
dc.subject.otherbiological model
dc.subject.otherdrug effect
dc.subject.otherdrug therapy
dc.subject.othermetabolism
dc.subject.othermitochondrion
dc.subject.otherpathology
dc.subject.othertherapy
dc.titleTherapeutic potential of adult stem cells-derived mitochondria transfer combined with curcumin administration into ARPE-19 cells in age-related macular degeneration model
dc.typeArticle
rdl.citation.openalex15
rdl.citation.scopus12
rdl.citation.wos12
rdl.departmentDepartment of Stem Cell, Institute of Health Sciences, Kocaeli University, Kocaeli, Turkey
rdl.departmentCenter for Stem Cell and Gene Therapies Research and Practice, Kocaeli University, Kocaeli, Turkey
rdl.departmentDepartment of Histology and Embryology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey
rdl.departmentDepartment of Therapy and Rehabilitation, European Vocational School, Kocaeli Health and Technology University, Kocaeli, Turkey
rdl.oa.statusclosed
rdl.scopus.quartileQ2
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)